ViewRay, Inc. (VRAYQ)
OTCMKTS: VRAYQ · Delayed Price · USD
0.0000
0.00 (0.00%)
Jul 19, 2024, 4:00 PM EDT - Market open
ViewRay Market Cap
ViewRay has a market cap or net worth of $1.83 thousand as of July 22, 2024. Its market cap has decreased by -100.00% in one year.
Market Cap
1.83K
Enterprise Value
-4.68M
1-Year Change
-100.00%
Ranking
n/a
Category
Stock Price
$0.00
Market Cap Chart
Since April 1, 2016, ViewRay's market cap has decreased from $163.90M to $1.83K, a decrease of -100.00%. That is a compound annual growth rate of -78.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2023 | 4.60M | -99.43% |
| Dec 30, 2022 | 812.70M | -10.47% |
| Dec 31, 2021 | 907.70M | 60.00% |
| Dec 31, 2020 | 567.30M | 35.23% |
| Dec 31, 2019 | 419.50M | -27.81% |
| Dec 31, 2018 | 581.10M | -6.96% |
| Dec 29, 2017 | 624.60M | 358.93% |
| Dec 30, 2016 | 136.10M | -16.96% |
| Apr 1, 2016 | 163.90M | - |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 814.94B |
| Novo Nordisk | 579.91B |
| UnitedHealth Group | 520.32B |
| Johnson & Johnson | 372.29B |
| Merck & Co. | 318.55B |
| AbbVie | 304.29B |
| AstraZeneca | 244.04B |
| Novartis AG | 207.64B |